#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • JNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments

    Recruiting

    1 1 1
    Investigated drugs:
    France Germany Greece Italy The Netherlands Norway +1

  • A Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1
    Investigated drugs:
    Italy Poland

  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1
    Investigated drugs:
    Germany Greece Norway Spain

  • Comparing CT-P44 and Darzalex Faspro with lenalidomide and dexamethasone in patients with refractory or relapsed multiple myeloma

    Recruiting

    1 1 1 1
    Investigated drugs:
    Poland Spain

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +11

  • Study Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +3

  • Study on Iberdomide, Cyclophosphamide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1
    Investigated drugs:
    The Netherlands

  • Study of Linvoseltamab in Adults with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1
    Investigated drugs:
    Belgium Spain

  • Study of Selinexor, Dexamethasone, and Bortezomib for Patients with Refractory Multiple Myeloma

    Recruiting

    1 1 1
    Investigated drugs:
    Greece

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Croatia Czechia Denmark Finland France +10